Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically‐based pharmacokinetic modelling: application to docetaxel

Abstract

This research shows the clinical utility of PBPK modelling in combination with population PK modelling and optimal design to support paediatric oncology development.